WallStreetZenWallStreetZen

NASDAQ: TNXP
Tonix Pharmaceuticals Holding Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Tonix Pharmaceuticals Holding revenue was $10.09M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $2.6M, down 8.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TNXP annual revenue was $10.1M, with 29.9% growth year-over-year.

TNXP past revenue growth

How has TNXP's revenue growth performed historically?

Company
29.94%
Industry
497.69%
Market
20.68%
TNXP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TNXP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TNXP's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TNXP revenue history

Current Revenue
$10.1M
Current Earnings
-$130.0M
Current Profit Margin
-1,288.3%

Be the first to know when TNXP announces revenue.

TNXP Revenue History By Year

TNXP Yearly RevenueTNXP RevenueTNXP ChangeTNXP Revenue Growth
2024-12-31$10.09M$2.33M+29.94%
2023-12-31$7.77MN/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A
2012-12-31$0.00N/AN/A
2011-12-31$0.00N/AN/A
2010-12-31$0.00N/AN/A
2009-12-31$0.00N/AN/A
2008-12-31$0.00N/AN/A

1 of 2

Tonix Pharmaceuticals Holding Revenue FAQ

What was TNXP's revenue last quarter?

On Invalid Date, Tonix Pharmaceuticals Holding (NASDAQ: TNXP) reported Q4 2024 revenue of $2.58 million up 31.68% year over year. In the same quarter last year, Tonix Pharmaceuticals Holding's revenue was $3.78 million.

What was Tonix Pharmaceuticals Holding's revenue in 2024?

Tonix Pharmaceuticals Holding's annual revenue for the twelve months ending Dec 31, 2024 was $10.09 million, a 29.94% increase year over year.

How much does Tonix Pharmaceuticals Holding make in a day?

Based on Tonix Pharmaceuticals Holding annual revenue for the past five years, TNXP makes an average of $9,787.40 per day.

What was Tonix Pharmaceuticals Holding's annual revenue growth in the past year?

As of Q2 2025, Tonix Pharmaceuticals Holding's revenue has grown 29.94% year over year. This is 467.75 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Tonix Pharmaceuticals Holding's revenue in the past year totaled $10.09 million.

How much does Tonix Pharmaceuticals Holding make in a year?

Tonix Pharmaceuticals Holding's revenue by year for the past five years is:
  • Tonix Pharmaceuticals Holding's revenue for the twelve months ending Dec 31, 2024 was $10.09 million, a 29.94% increase year over year.
  • Tonix Pharmaceuticals Holding's annual revenue for Dec 31, 2023 was $7.77 million, a Infinity% increase from 2022.
  • Tonix Pharmaceuticals Holding's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Tonix Pharmaceuticals Holding's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Tonix Pharmaceuticals Holding's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.